BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 37633647)

  • 1. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
    Park J; Cho J; Song EJ
    Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the ubiquitin-proteasome pathway in cancer development and treatment.
    Ding F; Xiao H; Wang M; Xie X; Hu F
    Front Biosci (Landmark Ed); 2014 Jun; 19(6):886-95. PubMed ID: 24896323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.
    Zou T; Lin Z
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the ubiquitin code in pancreatic cancer.
    Yang W; Wang S; Tong S; Zhang WD; Qin JJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166884. PubMed ID: 37704111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
    Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
    J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
    Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
    Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination in the regulation of inflammatory cell death and cancer.
    Cockram PE; Kist M; Prakash S; Chen SH; Wertz IE; Vucic D
    Cell Death Differ; 2021 Feb; 28(2):591-605. PubMed ID: 33432113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome-associated deubiquitinases and cancer.
    Mofers A; Pellegrini P; Linder S; D'Arcy P
    Cancer Metastasis Rev; 2017 Dec; 36(4):635-653. PubMed ID: 29134486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
    Landré V; Rotblat B; Melino S; Bernassola F; Melino G
    Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
    Chang SC; Zhang BX; Ding JL
    Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
    Staszczak M
    Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
    Lub S; Maes K; Menu E; De Bruyne E; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Feb; 7(6):6521-37. PubMed ID: 26695547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.